Biofarma Holding A/S: Financial statements 2023
CVR: 42243795
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Biofarma Holding A/S (CVR 42243795) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 4,938,666 compared with DKK -515,000 the year before. Equity in the 2023 report amounted to DKK 83,769,872. The solvency ratio was 99.5%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 4,938,666
- Equity
- DKK 83,769,872
- Total Assets
- DKK 84,178,811
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 0 | 4.9 mio. | 83.8 mio. | 0 |
| 2022 | 0 | 0 | -515 t. | 77.6 mio. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Biofarma Holding A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -515,000.
About Biofarma Holding A/S
Biofarma Holding A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Søren Wang Petersen. The board consists of Tyge Jesper Rothe (chair), Niels Christian Assens and Søren Wang Petersen. The company is owned by CAND.PHARM. POVL M. ASSENS FOND. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 10,281,000 compared with DKK 9,891,485 the year before. Equity in the 2025 report amounted to DKK 103,544,000.